These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32422251)

  • 1. Inhibition of 15-PGDH Protects Mice from Immune-Mediated Bone Marrow Failure.
    Smith JNP; Otegbeye F; Jogasuria AP; Christo KF; Antczak MI; Ready JM; Gerson SL; Markowitz SD; Desai AB
    Biol Blood Marrow Transplant; 2020 Aug; 26(8):1552-1556. PubMed ID: 32422251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 15-PGDH inhibition activates the splenic niche to promote hematopoietic regeneration.
    Smith JN; Dawson DM; Christo KF; Jogasuria AP; Cameron MJ; Antczak MI; Ready JM; Gerson SL; Markowitz SD; Desai AB
    JCI Insight; 2021 Mar; 6(6):. PubMed ID: 33600377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A second-generation 15-PGDH inhibitor promotes bone marrow transplant recovery independently of age, transplant dose and granulocyte colony-stimulating factor support.
    Desai A; Zhang Y; Park Y; Dawson DM; Larusch GA; Kasturi L; Wald D; Ready JM; Gerson SL; Markowitz SD
    Haematologica; 2018 Jun; 103(6):1054-1064. PubMed ID: 29472361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effectiveness of Rapamycin Combined with Eltrombopag in Murine Models of Immune-Mediated Bone Marrow Failure.
    Ding S; Liang X; Zhang T; Fu R
    J Immunol Res; 2020; 2020():1798795. PubMed ID: 33123600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel therapeutic choices in immune aplastic anemia.
    Scheinberg P
    F1000Res; 2020; 9():. PubMed ID: 32953089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of aplastic anemia in adolescence: a survey of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation.
    Dufour C; Pillon M; Passweg J; Socié G; Bacigalupo A; Franceschetto G; Carraro E; Oneto R; Risitano AM; Peffault de Latour R; Tichelli A; Rovo A; Peters C; Hoechsmann B; Samarasinghe S; Kulasekararaj AG; Schrezenmeier H; Aljurf M; Marsh J
    Haematologica; 2014 Oct; 99(10):1574-81. PubMed ID: 25085353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.
    Führer M; Burdach S; Ebell W; Gadner H; Haas R; Harbott J; Janka-Schaub G; Klingebiel T; Kremens B; Niemeyer C; Rampf U; Reiter A; Ritter J; Schulz A; Walther U; Zeidler C; Bender-Götze C
    Klin Padiatr; 1998; 210(4):173-9. PubMed ID: 9743949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT.
    Dufour C; Veys P; Carraro E; Bhatnagar N; Pillon M; Wynn R; Gibson B; Vora AJ; Steward CG; Ewins AM; Hough RE; de la Fuente J; Velangi M; Amrolia PJ; Skinner R; Bacigalupo A; Risitano AM; Socie G; Peffault de Latour R; Passweg J; Rovo A; Tichelli A; Schrezenmeier H; Hochsmann B; Bader P; van Biezen A; Aljurf MD; Kulasekararaj A; Marsh JC; Samarasinghe S
    Br J Haematol; 2015 Nov; 171(4):585-94. PubMed ID: 26223288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upfront eltrombopag monotherapy induces stable hematologic remission in pediatric patients with nonsevere idiopathic aplastic anemia.
    Geng W; Kearney S; Nelson S
    Pediatr Blood Cancer; 2018 Oct; 65(10):e27290. PubMed ID: 29932285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TISSUE REGENERATION. Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration.
    Zhang Y; Desai A; Yang SY; Bae KB; Antczak MI; Fink SP; Tiwari S; Willis JE; Williams NS; Dawson DM; Wald D; Chen WD; Wang Z; Kasturi L; Larusch GA; He L; Cominelli F; Di Martino L; Djuric Z; Milne GL; Chance M; Sanabria J; Dealwis C; Mikkola D; Naidoo J; Wei S; Tai HH; Gerson SL; Ready JM; Posner B; Willson JK; Markowitz SD
    Science; 2015 Jun; 348(6240):aaa2340. PubMed ID: 26068857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cell-derived extracellular vesicles conditionally ameliorate bone marrow failure symptoms in an immune-mediated aplastic anemia mouse model.
    Gholampour MA; Abroun S; Nieuwland R; Mowla SJ; Soudi S
    J Cell Physiol; 2021 Aug; 236(8):6055-6067. PubMed ID: 33492726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic targeting of 15-PGDH in murine pulmonary fibrosis.
    Smith JNP; Witkin MD; Jogasuria AP; Christo KF; Raffay TM; Markowitz SD; Desai AB
    Sci Rep; 2020 Jul; 10(1):11657. PubMed ID: 32669620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and Treatment of Aplastic Anemia.
    Peslak SA; Olson T; Babushok DV
    Curr Treat Options Oncol; 2017 Nov; 18(12):70. PubMed ID: 29143887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive therapy in severe aplastic anemia.
    Patel BA; Townsley DM; Scheinberg P
    Semin Hematol; 2022 Jan; 59(1):21-29. PubMed ID: 35491055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mouse model of lymphocyte infusion-induced bone marrow failure.
    Bloom ML; Wolk AG; Simon-Stoos KL; Bard JS; Chen J; Young NS
    Exp Hematol; 2004 Dec; 32(12):1163-72. PubMed ID: 15588941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombopoietin receptor agonists for marrow failure: A concise clinical review.
    Kapoor S; Champion G; Olnes MJ
    Best Pract Res Clin Haematol; 2021 Jun; 34(2):101274. PubMed ID: 34404526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of aplastic anaemia in children. A study by the severe aplastic anaemia and paediatric disease working parties of the European group blood and bone marrow transplant.
    Dufour C; Pillon M; Sociè G; Rovò A; Carraro E; Bacigalupo A; Oneto R; Passweg J; Risitano A; Tichelli A; Peffault de Latour R; Schrezenmeier H; Hocshmann B; Peters C; Kulasekararaj A; Van Biezen A; Samarasinghe S; Hussein AA; Ayas M; Aljurf M; Marsh J
    Br J Haematol; 2015 May; 169(4):565-73. PubMed ID: 25683884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of the refractory aplastic anemia patient: what are the options?
    Marsh JC; Kulasekararaj AG
    Blood; 2013 Nov; 122(22):3561-7. PubMed ID: 24052548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic stem cell transplantation for high-risk adult patients with severe aplastic anemia; reduction of graft failure by enhancing stem cell dose.
    Min CK; Kim DW; Lee JW; Han CW; Min WS; Kim CC
    Haematologica; 2001 Mar; 86(3):303-10. PubMed ID: 11255278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis.
    Barker JN; Davies SM; DeFor T; Ramsay NK; Weisdorf DJ; Wagner JE
    Blood; 2001 May; 97(10):2957-61. PubMed ID: 11342417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.